BAROnova

BAROnova, Inc. is a venture-backed company headquartered in Silicon Valley that has developed a novel, non-surgical solution for obesity. BAROnova's TransPyloric Shuttle®* (TPS®) is designed to slow gastric emptying, thereby creating a longer and more pronounced sensation of fullness—a proven method for weight loss. During a simple 15-minute outpatient procedure, the TPS is placed endoscopically and removed in a similar manner. The device can remain in the patient for up to 12 months to assist with weight loss.The global market for this treatment exceeds 600 million people, with 75 million in the United States alone.BAROnova recently completed the ENDO Obesity II Study, a 12-month U.S. multicenter pivotal trial aimed at evaluating the safety and efficacy of the TransPyloric Shuttle.